EMA Authorised: Zonegran (zonisamide) — Amdipharm Limited

View source ↗

Summary

EMA authorises Zonegran (zonisamide) by Amdipharm Limited for partial epilepsies in Europe.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsies Partial

Drugs mentioned

• Zonegran (zonisamide)

Snippet

Status: Authorised. Therapeutic area: Epilepsies, Partial. MAH: Amdipharm Limited. Decision date: 21/07/2026